Why the study?
Does activation of the central renin-angiotensin system cause local cerebrovascular dysfunction in a preclinical model of hypertension?
Does activation of the central renin-angiotensin system cause local cerebrovascular dysfunction in a preclinical model of hypertension?
Activation of the central renin-angiotensin system impairs brain endothelial signaling, suggesting a common mechanism for vascular dysfunction in hypertension, aging, and other diseases.
Answers are grounded in this paper and cite their sources.
Suggests central RAS inhibition as potential strategy against cerebrovascular dysfunction; leaves open translation from animal models to human hypertension.
These findings suggest activation of the central and cerebrovascular RAS impairs endothelial (nitric oxide dependent) signaling in brain through expression and activation of AT1R and sex-dependent effects. The central RAS may be a key contributor to vascular dysfunction in brain in a preclinical (low renin) model of hypertension. Because the brain RAS is also activated during aging and other diseases, a common mechanism may promote loss of endothelial and brain health despite diverse cause.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: